Product Information
FUROSEMIDE 40 MG/4 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.3189 per ML under NDC 63323028004. Its NADAC has been published 163 times since May 17, 2023.
Strength
10 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323028004
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
FUROSEMIDEApproval Type
New Drug (NDA)
FDA Application
NDA018902On Market Since
7/12/2000
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 40 MG/4 ML VIAL has been published 163 times since May 17, 2023, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3189 per ML |
|---|---|
| All-time high | $0.5940 (Apr 10, 2024) |
| All-time low | $0.2231 (Jun 18, 2025) |
| 52-week high | $0.3500 |
| 52-week low | $0.2231 |
| Median price | $0.3027 |
| Average price | $0.3276 |
| Largest weekly change | +72.8% (Nov 22, 2023) |
| Weeks tracked | 163 |
| Tracking since | May 17, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FUROSEMIDE 40 MG/4 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 40 MG/4 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.3189 per ML (NDC 63323028004), effective Jun 24, 2026.
How has the price of FUROSEMIDE 40 MG/4 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has declined 7.2%. It has been tracked across 163 weekly CMS publications since May 17, 2023.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 40 MG/4 ML VIAL?
Since May 17, 2023, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has ranged from a low of $0.2231 (Jun 18, 2025) to a high of $0.5940 (Apr 10, 2024), with a median of $0.3027 per ML.
Are there cheaper alternatives to FUROSEMIDE 40 MG/4 ML VIAL?
3 NADAC-published products share the same active ingredient, strength, and dosage form as FUROSEMIDE 40 MG/4 ML VIAL, but none are currently priced below it.
Who manufactures FUROSEMIDE 40 MG/4 ML VIAL?
FUROSEMIDE 40 MG/4 ML VIAL (NDC 63323028004) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification